Advertisement

Non-Disseminated Breast Cancer

Controversial Issues in Management

  • Gilbert H. Fletcher
  • Seymour H. Levitt
Book

Part of the Medical Radiology book series (MEDRAD)

Table of contents

  1. Front Matter
    Pages I-XIV
  2. Gilbert H. Fletcher
    Pages 1-3
  3. Walter Lawrence Jr., Gilbert H. Fletcher
    Pages 5-9
  4. Robert T. Osteen
    Pages 27-34
  5. Nigel P. M. Sacks, Roger P. A’Hern, Michael Baum
    Pages 35-42
  6. Richard J. Epstein, I. Craig Henderson
    Pages 43-56
  7. Eric A. Strom, Marsha D. McNeese, Gilbert H. Fletcher
    Pages 57-72
  8. Seymour H. Levitt, Lars-Erik Rutqvist
    Pages 73-81
  9. Robert M. Goldwyn
    Pages 155-160
  10. Back Matter
    Pages 161-168

About this book

Introduction

In the last two decades, there has been a major increase in the actual numbers of women diagnosed with breast cancer (from 65000 new cases 20 years ago in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-stage disease in 1992). These changes are clearly related to the woman's greater sensitivity to abnormalities in the breast and her seeking medical care, to the physician's greater awareness of the potential diagnosis of cancer, and to the major and important impact of mammographic screening. These changes have had a major impact on the questions of appropriate treatment, thereby contributing to the controversies in the disease. What is the role of surgery? What are the respective advantages of radical mastectomy, modified radical mastectomy, and conservation surgery with and without supplementary treatment? What is the role of radiation therapy? When should radiation therapy be performed after mastectomy, and what volumes should be irradiated post mastectomy? Where is radiation therapy indicated after conservation surgery, and when is radiation therapy an effective palliative treatment measure? When should chemotherapy and/or hormonal therapy be used as an adjuvant to primary treatment and when as an effective palliative treatment? This book by Levitt and Fletcher addresses these critical and important issues.

Keywords

Brustkrebs Onkologie breast cancer cancer carcinoma chemotherapy clinical trial nondiseminated breast cancer oncology pathology radiation radiation therapy radiology radiotherapy surgery

Editors and affiliations

  • Gilbert H. Fletcher
    • 1
  • Seymour H. Levitt
    • 2
  1. 1.Department of RadiotherapyM.D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of Therapeutic Radiology - Radiation OncologyUniversity of MinnesotaMinneapolisUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-84593-2
  • Copyright Information Springer-Verlag Berlin Heidelberg 1993
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-84595-6
  • Online ISBN 978-3-642-84593-2
  • Series Print ISSN 0942-5373
  • Buy this book on publisher's site